What is eCOA and ePRO.pdf
IKCS 2022: The New Era of Clinical Trials: Meeting Regulatory Requirements and Decreasing Barriers
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study - The Lancet Oncology
PDF) Patient-reported outcomes: A new era in clinical research
Clinical trial - Wikipedia
Artificial Intelligence for Clinical Trial Design: Trends in Pharmacological Sciences
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection | Nature Communications
Patient-Centered Endpoints - Clinical Outcome Assessment (COA) - IQVIA
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
Digital clinical trials: a new era - LaingBuisson News
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology
COVID-19 Opens a New Era for Real-World Evidence in Pharma | BCG
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease - ScienceDirect
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension | Nature Medicine
Frontiers | Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
Stepping up the decentralization of clinical trials | McKinsey
